Please assess the completion status of the following clinical trial:

Trial Title: Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During EBUS-TBNA

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Indication for EBUS TBNA~* Age \> 18 years~Exclusion Criteria:~* Refusal of consent~* Known documented hypersensitivity to lignocaine~* Procedure performed under general anaesthesia~* Pregnancy~* Hypoxemia (oxygen saturation \[by pulse oximetry\] \< 92% with Fio2 of ≥ 0.3~* Bronchoscopy done through endotracheal or tracheostomy tube~* Midline neck mass or thyroid enlargement making the identification of~* cricothyroid membrane difficult'~* Patients with central airway obstruction~* Patients with active ongoing hemoptysis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Transcricoid (Type: ACTIVE_COMPARATOR): Lignocaine delivery using transcricoid injection
- Spray as You go (Type: ACTIVE_COMPARATOR): Lignocaine delivery using spray as you go method

Based on this trial design, predict the completion outcome and termination type (if applicable).